Common Contracts
10 similar null contracts by Geron Corp
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT AGeron Corp • February 28th, 2008 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, ________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ______________ (________) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at a per share exercise price equal to the lesser of (i) average of the closing bid prices of the Common Stock on the Principal Exchange (as defined in that certain Securities Purchase Agreement dated as of November 10, 2004, by and among the Company and the Buyers listed therein (the "Purchase Agreement")) for the five (5) Trading Day (as defined in the Purchase Agreement) period ending on December 15, 2009 and (ii) $7.50 (the "Exercise Price"); provided, however, that the Exercise Price shall not be less than $6.80, except as adjusted pursuant to Section 4 hereof.
FORM OF AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT DGeron Corp • February 28th, 2008 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, ________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ______________ (________) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at a per share exercise price equal to the lesser of (i) average of the closing bid prices of the Common Stock on the Principal Exchange (as defined in that certain Securities Purchase Agreement, dated as of December 13, 2006, by and among the Company and the Buyers listed therein (the "Purchase Agreement")) for the five (5) Trading Day (as defined in the Purchase Agreement) period ending on December 15, 2009 and (ii) $7.50 (the "Exercise Price"); provided, however, that the Exercise Price shall not be less than $6.80, except as adjusted pursuant to Section 4 hereof.
FORM OF AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT AGeron Corp • February 28th, 2008 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, ________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ______________ (________) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at a per share exercise price equal to the lesser of (i) average of the closing bid prices of the Common Stock on the Principal Exchange (as defined in that certain Securities Purchase Agreement dated as of December 13, 2006, by and among the Company and the Buyers listed therein (the "Purchase Agreement")) for the five (5) Trading Day (as defined in the Purchase Agreement) period ending on December 15, 2009 and (ii) $7.50 (the "Exercise Price"); provided, however, that the Exercise Price shall not be less than $6.80, except as adjusted pursuant to Section 4 hereof.
COMMON STOCK PURCHASE WARRANT DGeron Corp • April 30th, 2007 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, ____________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ____________ (______) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at a per share exercise price equal to the lesser of (i) 120% of the average of the closing bid price of the Common Stock on the Principal Exchange (as defined in that certain Securities Purchase Agreement, dated December 13, 2006, by and among the Company and the Buyers listed on the execution page thereof (the "Purchase Agreement")) for the five (5) Trading Day (as defined in the Purchase Agreement) period immediately prior to the Exercise Period Start Date (as defined below) and (ii) $12.14 (the "Exercise Price"). The term "Warrant Shares," as used herein, refers to the shares of Comm
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT AGeron Corp • April 30th, 2007 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, __________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ____________ (_______) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at a per share exercise price equal to the lesser of (i) 120% of the average of the closing bid price of the Common Stock on the Principal Exchange (as defined in that certain Securities Purchase Agreement, dated December 13, 2006, by and among the Company and the Buyers listed on the execution page thereof (the "Purchase Agreement")) for the five (5) Trading Day (as defined in the Purchase Agreement) period immediately prior to the Exercise Period Start Date (as defined below) and (ii) $12.14 (the "Exercise Price"). The term "Warrant Shares," as used herein, refers to the shares of Commo
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT CGeron Corp • April 30th, 2007 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, __________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ____________ (_______) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at an exercise price of $0.01 per share (the "Exercise Price"). The term "Warrant Shares," as used herein, refers to the shares of Common Stock purchasable hereunder. The Warrant Shares are subject to adjustment as provided in Paragraph 4 hereof. The term "Warrants" means this Warrant and the other warrants (including the A Warrants and the B Warrants (each as defined in the Purchase Agreement)) issued pursuant to that certain Securities Purchase Agreement, dated December 13, 2006, by and among the Company and the Buyers listed on the execution page thereof (the "Purchase Agreement").
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT AGeron Corp • March 16th, 2007 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, ___________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ___________ (______) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at a per share exercise price equal to the lesser of (i) 120% of the average of the closing bid price of the Common Stock on the Principal Exchange (as defined in that certain Securities Purchase Agreement, dated December 13, 2006, by and among the Company and the Buyers listed on the execution page thereof (the "Purchase Agreement")) for the five (5) Trading Day (as defined in the Purchase Agreement) period immediately prior to the Exercise Period Start Date (as defined below) and (ii) $12.14 (the "Exercise Price"). The term "Warrant Shares," as used herein, refers to the shares of Common
COMMON STOCK PURCHASE WARRANT DGeron Corp • March 16th, 2007 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, _________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ____________ (______) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at a per share exercise price equal to the lesser of (i) 120% of the average of the closing bid price of the Common Stock on the Principal Exchange (as defined in that certain Securities Purchase Agreement, dated December 13, 2006, by and among the Company and the Buyers listed on the execution page thereof (the "Purchase Agreement")) for the five (5) Trading Day (as defined in the Purchase Agreement) period immediately prior to the Exercise Period Start Date (as defined below) and (ii) $12.14 (the "Exercise Price"). The term "Warrant Shares," as used herein, refers to the shares of Common
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT CGeron Corp • March 16th, 2007 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, ___________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, ____________ (______) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at an exercise price of $0.01 per share (the "Exercise Price"). The term "Warrant Shares," as used herein, refers to the shares of Common Stock purchasable hereunder. The Warrant Shares are subject to adjustment as provided in Paragraph 4 hereof. The term "Warrants" means this Warrant and the other warrants (including the A Warrants and the B Warrants (each as defined in the Purchase Agreement)) issued pursuant to that certain Securities Purchase Agreement, dated December 13, 2006, by and among the Company and the Buyers listed on the execution page thereof (the "Purchase Agreement").
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT AGeron Corp • March 16th, 2007 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, __________ or its registered assigns (the “Holder”), is entitled to purchase from Geron Corporation, a Delaware corporation (the "Company"), at any time or from time to time during the period specified in Paragraph 2 hereof, _________ (_____) fully paid and nonassessable shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), at an exercise price of $8.62 per share (the "Exercise Price"). The term "Warrant Shares," as used herein, refers to the shares of Common Stock purchasable hereunder. The Warrant Shares and the Exercise Price are subject to adjustment as provided in Paragraph 4 hereof. The term "Warrants" means this Warrant and the other warrants (including the B Warrants and the C Warrants (each as defined in the Purchase Agreement)) issued pursuant to that certain Securities Purchase Agreement, dated November 10, 2004, by and among the Company and the Buyers listed on the execution page thereof (the "Purchas
